Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.36 - $36.0 $96,381 - $9.64 Million
267,726 Added 2350.54%
279,116 $511,000
Q2 2022

Aug 15, 2022

SELL
$12.3 - $27.3 $5.02 Million - $11.1 Million
-408,316 Reduced 97.29%
11,390 $16,000
Q1 2022

May 16, 2022

BUY
$16.6 - $32.3 $6.13 Million - $11.9 Million
369,220 Added 731.33%
419,706 $1.08 Million
Q4 2021

Feb 14, 2022

BUY
$29.9 - $61.2 $1.51 Million - $3.09 Million
50,486 New
50,486 $151,000
Q3 2021

Nov 15, 2021

SELL
$51.4 - $68.2 $570,334 - $756,747
-11,096 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$44.1 - $84.0 $489,333 - $932,064
11,096 New
11,096 $81,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.